FDA Reports Further Support for Canagliflozin-Amputation Link FDA Reports Further Support for Canagliflozin-Amputation Link

The data are still insufficient to change prescribing recommendations, but they do suggest caution in prescribing canagliflozin for people at increased amputation risk.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news